Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
about
Stabilization of high-risk plaquesThe HOPE (Heart Outcomes Prevention Evaluation) Study and its consequencesThe choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.Predictors of Plaque Progression in Hypertensive Angina Patients with Achieved Low-Density Lipoprotein Cholesterol Less Than 70 mg/dL after Rosuvastatin Treatment.Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information systemThe impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease.Evidence based cardiology: emerging approaches in preventing cardiovascular disease.Redox regulation, NF-kappaB, and atrial fibrillation.Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?Summary of randomized trials of angiotensin converting enzyme inhibitors.Use of renin-angiotensin inhibitors in people with renal artery stenosisMitochondria and arrhythmias.ACE inhibitors and high-risk patientsTherapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure.Vasopeptidase inhibition: a new direction in cardiovascular treatment.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusClinical Evidence: Emerging approaches in preventing cardiovascular disease.Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension.Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.Appropriate use of calcium antagonists in hypertension.Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderlyTelmisartan to prevent recurrent stroke and cardiovascular events.Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.Association between angiotensin-converting enzyme inhibitors and troponin in acute coronary syndrome.The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykininIrbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation.Modulating atherosclerosis through inhibition or blockade of angiotensin.Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trialLeft ventricular dysfunction: causes, natural history, and hopes for reversal.Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death.Reversal of experimental renovascular hypertension restores coronary microvascular function and architectureThe potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease.Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction.Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin-angiotensin system.Hypotension due to interaction between lisinopril and tizanidine.Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan.
P2860
Q26738584-B3B9E8A4-74D8-4D98-896D-88A67D045623Q28188518-5CC3DAE3-B970-4750-AD52-F1B15868E8A8Q30310671-A3DAD15B-A0D8-47DF-939D-1B5BC62D0557Q30394491-1CF4DC82-F8B0-4A5B-85A1-63C489DC31B1Q33390497-BBAC956D-BC4E-4245-9151-A9C02D9AC284Q33615444-16BCD5BC-5420-4E93-BDC4-2B75259E17E6Q33633505-61C09AE0-314B-492F-BA9C-7A484F239A41Q33644314-340FF201-434A-46D8-A5B3-EA716F3417E1Q33654306-9FC7DD43-196C-448D-A833-E7C6C9285C1AQ33697681-FB0CE7E3-9F9B-4600-9CB6-2E75FA875B90Q33835760-30641F97-DE37-4110-A7EE-72C0E55C0279Q33896746-C30DFC50-0330-47B6-AE41-02F4A671CDBBQ33954444-7E24CC2D-02D8-417A-B559-A17F8765A1C5Q34027512-5F7A65BC-E358-4024-B5E0-2547FA8FDF40Q34028620-AC125DBF-BF1E-48E6-81EB-43B36E6175F6Q34124779-40D27909-99B3-4632-A6B7-26E280D92CA7Q34191507-0147D766-2D97-4FE6-A5D9-90EBD01ACC1DQ34324368-565C602C-4C9C-4604-A98E-5F90480C9142Q34332911-83A9A519-870E-4F7C-BB00-384FB648FFB3Q34375330-6DD9CE55-E74C-4D5B-95B0-7BEDEE7F6AA8Q34386587-9038B21A-5DD2-463B-A72B-DBF3806E0482Q34596294-27812D01-FB52-4CB2-8995-F2D60FD70376Q34906496-0FE02C48-448E-4551-B5BA-370325D694DCQ34914616-85A99E5D-8A19-455D-9CE5-A5F192EF493BQ35041955-35F32E27-70B6-4DDD-BDC8-9D46C0DF4427Q35047383-F50E094E-B1C9-4355-A25D-349C7A4C53D8Q35087527-A687E109-6683-4983-AC17-F71371EFA558Q35176717-C03A8C1A-5202-44BB-A456-3C78C5EAF35BQ35178446-4272063B-ED76-4866-A38D-3E2781B219A7Q35215135-B50954BD-4045-4F06-914F-6442EF66E236Q35252620-CC7BE0E9-C282-41F7-989B-677C8F30A592Q35578952-40F97BED-2D02-4A0F-ACB4-B8362E485A72Q35580826-33FC562C-5207-45B4-9726-56ED1C3E257DQ35628592-FE1E3490-5F89-4827-A165-29F7C06D250FQ35763822-62C273B4-9005-408B-AA74-30B8E6D0AC28Q35800634-0BF41231-A222-48B7-B012-4814FEED2B80Q35830576-C163F555-FFB4-45FF-B772-C49899AFBEB3Q35837140-755AA029-CCB8-4F50-B189-17E18E81442BQ35895193-660DB40D-3510-48F2-A8E4-BEF6FBECBDFBQ36014340-4F31523C-848E-477A-ACC5-B1EF6D4EA5B3
P2860
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Emerging role of angiotensin-c ...... rdiac and vascular protection.
@en
type
label
Emerging role of angiotensin-c ...... rdiac and vascular protection.
@en
prefLabel
Emerging role of angiotensin-c ...... rdiac and vascular protection.
@en
P2093
P356
P1433
P1476
Emerging role of angiotensin-c ...... rdiac and vascular protection.
@en
P2093
Benedict CR
Montague TJ
P304
P356
10.1161/01.CIR.90.4.2056
P407
P577
1994-10-01T00:00:00Z